ArticleScientific reports2025
Leveraging ensemble convolutional neural networks and metaheuristic strategies for advanced kidney disease screening and classification.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Applications of artificial intelligence in chronic kidney disease: a systematic review.Revista de saude publica · 2026Pooled it
- A Robust Intelligent CNN Model Enhanced with Gabor-Based Feature Extraction, SMOTE Balancing, and Adam Optimization for Multi-Grade Diabetic Retinopathy Classification.Journal of imaging · 2026Article
- Kidney Segmentation of Histopathological Images with Edge-Aware U-Net to Support Medical Diagnosis and Treatment Planning.Bioengineering (Basel, Switzerland) · 2026Article
- Uncertainty-Aware Framework for CT Radiation Dose Optimization in the Active Surveillance of Small Renal Masses: Clinical and Radiological Considerations.Diagnostics (Basel, Switzerland) · 2026Article
- A novel approach for breast cancer detection using a Nesterov accelerated adam optimizer with an attention mechanism.Scientific reports · 2025Article
- Deep learning in renal ultrasound: applications, challenges, and future outlook.Frontiers in oncology · 2025Review
- Detection of protein-losing enteropathy (PLE) ultrasonographic imaging features in dogs using deep learning neural networks.Frontiers in artificial intelligence · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To address the public health issue of renal failure and the global shortage of nephrologists, an AI-based system has been developed to automatically identify kidney diseases. Recent advancements in machine learning, deep learning (DL), and artificial intelligence (AI) have unlocked new possibilities in healthcare. By harnessing these technologies, we can analyze data to gain insights into symptoms and patterns, ultimately facilitating remote patient care. To create an AI-based diagnosis system for kidney disease, this paper focused on the three major categories of kidney diseases: stones, cysts, and tumors, which were collected and annotated on 12,446 computed tomography (CT) whole abdomen and urogram images. To effectively aid in the automatic identification and diagnosis of kidney diseases, a novel DL model built on the transfer-learning (TL) technology is implemented in this work. DL models are designed to focus on problems, whereas TL uses the knowledge acquired while resolving one issue to another pertinent issue. The proposed model combines multiple DL models to improve overall performance by leveraging the strengths of different architectures, ensembles can enhance accuracy, robustness, and generalization. It enhances the features extracted from MobileNet-V2, ResNet50, and EfficientNet-B0 networks using metaheuristic algorithms and bidirectional long-short-term memory (Bi-LSTM) from the CT image. MobileNetV2, ResNet50, and EfficientNet-B0 hyperparameters have been optimized using a modified grey wolf optimization (GWO) approach for better performance. The suggested model's performance has been measured using five assessment metrics: accuracy, sensitivity, specificity, precision, and area under the ROC curve (AUC) and achieved 99.85% accuracy, 99.8% sensitivity, 99.3% specificity, 98.1% precision, and 1.0 AUC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.